MYGN CIK: 899923

Myriad Genetics, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.48
FY22:
0.27
FY23:
0.31
FY24:
0.30
FY25:
0.33
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.84
FY22:
0.92
FY23:
0.83
FY24:
0.73
FY25:
0.37
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.32
FY22:
1.20
FY23:
1.15
FY24:
1.03
FY25:
0.71

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.14
FY23:
0.16
FY24:
0.16
FY25:
0.13
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.15
FY22:
0.18
FY23:
0.21
FY24:
0.16
FY25:
0.20
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.97
FY22:
0.89
FY23:
0.78
FY24:
0.70
FY25:
0.37
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.32
FY22:
1.20
FY23:
1.15
FY24:
1.03
FY25:
0.71

All amounts in billions USD Data source:SEC EDGAR